Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Pharma
The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K
Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
Aug 28, 2026 9:30am
Lilly covers aging and obesity in new GLP-1 access campaign
Aug 24, 2026 4:02pm
What did we learn from Big Pharma’s Q2 results?
Aug 21, 2026 9:47am
Novo testing smaller doses of Wegovy pill in phase 3 study
Aug 20, 2026 8:51am
Fierce Biotech
Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
Aug 7, 2026 9:08am
Novo escalates Lilly ad suit, plans bid to halt comparative ads
Jul 24, 2026 10:45am